Operating partner at Asabys, Emilio joined the team in December 2024. Emilio supports our biopharma portfolio investments in strategy and business development and currently holds the CBO role at ALLOX.
Previously, Emilio led external innovation deals at Boehringer Ingelheim, as Director of Global BD&L Oncology, contributing novel pipeline assets and technology platforms. Emilio has fostered pharma-biotech relationships across Europe, the US and Japan, and served as consultant for the industry. He trained as a neuroscientist at the Max Planck Institute for Multidisciplinary Sciences in Germany.
Emilio received an MBA from IE Business School in 2008, his PhD in Neuroscience from the University of Göttingen in 2006, and a Molecular Biotechnology Engineering degree from the University of Chile in 2002.
